Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Incyte 1.674, Becton Dickinson 4.983.
Incyte vs Becton Dickinson: Revenue Comparison
Incyte (INCY) and Becton Dickinson (BDX) are peers in Healthcare. Incyte reported revenue of $1.7B as of Q2 2026, compared with $5.0B for Becton Dickinson. Becton Dickinson leads on revenue.
Incyte's gross margin is 93.7% versus 46.5% for Becton Dickinson. Incyte's net margin is 35.0% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Incyte, Becton Dickinson.| Metric | Incyte | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $1.67B | $4.98B |
| Cost of Revenue | $105.00M | $2.67B |
| Gross Profit | $1.57B | $2.31B |
| Operating Income | $698.00M | $663.00M |
| Net Income | $586.00M | $377.00M |
| R&D Expense | $517.00M | $258.00M |
| Earnings Per Share | $2.81 | $1.37 |
| Gross Margin | 93.7% | 46.5% |
| Operating Margin | 41.7% | 13.3% |
| Net Profit Margin | 35.0% | 7.6% |
| Free Cash Flow | $495.00M | $509.00M |
| Cumulative Free Cash Flow | $3.86B | $39.60B |
| Operating Cash Flow | $508.00M | $652.00M |
| Cash & Equivalents | $3.98B | $708.00M |